Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05915078 · ClinicalTrials.gov registry record
Evaluation of Outcomes Following In-office Tympanostomy Using the Tula® System: a Prospective, Multi-center Registry
A clinical trial of Otitis Media and Acute Otitis Media, sponsored by Smith & Nephew.
- Recruiting
- Registry status
- 200
- Enrollment target
- 6
- Study locations
NCT05915078: Recruiting study of Otitis Media and Acute Otitis Media, sponsored by Smith & Nephew.
NCT05915078 is a study of Otitis Media and Acute Otitis Media that is actively recruiting participants, run by Smith & Nephew. The registered enrollment target is 200 participants, below the 4,329-participant average among 14 other Otitis Media trials with a reported enrollment target (95% lower). The trial reports 6 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05915078, a study of Otitis Media and Acute Otitis Media, is actively recruiting participants, sponsored by Smith & Nephew.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 6
- Study locations
Study Summary
This prospective, single-arm, multicenter registry is being conducted to collect real world post-market data from patients aged from 6 months to 17 years of age who are undergoing an in-office ear tube placement procedure (tympanostomy) using the Tula® System. The Registry will include up to 20 centers in the US and up to 200 patients for the initial evaluation. The FDA-approved Tula System includes the Tula Iontophoresis System (IPS) with TYMBION™ otic anesthetic for local anesthesia of the ear drum and the Tula Tube Delivery System (TDS) for ear tube placement. Clinical research established the safety, efficacy and tolerability of this system for in-office procedures in the pediatric population. Patients will be treated and evaluated according to standard medical care. Outcome data is collected up to 6 months following extrusion or removal of their tube(s).
Primary Outcome
Count (and percentage) of patients with successful placement of Tula Tympanostomy Tubes in all indicated ears in an office procedure
Conditions Studied
Interventions
- COMBINATION_PRODUCT Iontophoresis and tube placement
Study Locations (6)
New Jersey
- Regional Otolaryngology Head and Neck Associates - Cherry Hill
- Rutgers Robert Wood Johnson Medical School - New Brunswick
Utah
- Ogden Clinic - Professional Center North - Ogden
- Peak Pediatric Ear, Nose and Throat - Provo
Kentucky
- Advanced ENT and Allergy - Louisville
New York
- Columbia University Vagelos College of Physicians and Surgeons - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2023-06-15 |
| Est. Completion | 2027-06-30 |
What NCT05915078 shows while recruiting
NCT05915078 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 4,329-participant average among 14 other Otitis Media trials with a reported enrollment target (95% lower).
The record links to 3 conditions, with Otitis Media appearing as the primary indexed condition, and to 1 intervention - of which Iontophoresis and tube placement is the first listed.
NCT05915078 lists 6 locations in 4 states (New Jersey, Utah, Kentucky).
Frequently Asked Questions
What is clinical trial NCT05915078 about?
NCT05915078 is a clinical study titled "Evaluation of Outcomes Following In-office Tympanostomy Using the Tula® System: a Prospective, Multi-center Registry". This prospective, single-arm, multicenter registry is being conducted to collect real world post-market data from patients aged from 6 months to 17 years of age who are undergoing an in-office ear tube placement procedure (tympanostomy) using the Tula® System. The Registry will include up to 20 cent...
What is the current status of trial NCT05915078?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2023-06-15. Estimated completion is 2027-06-30.
What conditions does trial NCT05915078 study?
This clinical trial studies the following conditions: Otitis Media, Acute Otitis Media, Otitis Media With Effusion.
What interventions are being tested in trial NCT05915078?
The interventions under investigation include: Iontophoresis and tube placement (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT05915078?
This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05915078 being conducted?
This trial has 6 study locations across Kentucky, New Jersey, New York, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Otitis Media
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05915078's enrollment target sits among peer trials
200 7th of 14 higher than 8 of 14 other Otitis Media trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Otitis Media trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Does Topical Otic Drop Use at Time of Tympanostomy Tube Surgery Improve Outcomes When no Middle Ear Effusion is Present
RECRUITING · Phase 4
-
In-Office Clinical Study of the Solo+ TTD
RECRUITING · NA
-
Coherent Optical Detection of Middle Ear Disease
RECRUITING · NA
-
Digital Otoscope Versus Education and Feedback for Otitis Media in Young Children
ACTIVE NOT RECRUITING · NA
-
Diagnostic Utility of Otosight Middle Ear Scope
ACTIVE NOT RECRUITING
-
Improving Otitis Media Care With Clinical Decision Support
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI